Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
The bad behavior exhibited by lower-quality companies in this space can spook even the most seasoned professionals, which is why we started StockStory - to separate the good from the bad. That said, here are three stocks under $10 to swipe left on and some alternatives you should look into instead.
Jamf (JAMF)
Share Price: $10
With its name playfully derived from "Just Another Management Framework," Jamf (NASDAQ: JAMF) provides software that helps organizations deploy, manage, and secure Apple devices across their workforce while maintaining a seamless user experience.
Why Does JAMF Fall Short?
- Underwhelming ARR growth of 11.1% over the last year suggests the company faced challenges in acquiring and retaining long-term customers
- Estimated sales growth of 10.3% for the next 12 months implies demand will slow from its two-year trend
- Suboptimal cost structure is highlighted by its history of operating margin losses
At $10 per share, Jamf trades at 1.8x forward price-to-sales. Dive into our free research report to see why there are better opportunities than JAMF.
Skillz (SKLZ)
Share Price: $7.13
Taking a new twist at video gaming, Skillz (NYSE: SKLZ) offers developers a platform to create and distribute mobile games where players can pay fees to compete for cash prizes.
Why Should You Sell SKLZ?
- Intense competition is diverting traffic from its platform as its paying monthly active users fell by 24.5% annually
- Cash burn has widened over the last few years, making us question whether it can reliably generate shareholder value
- Limited cash reserves may force the company to seek unfavorable financing terms that could dilute shareholders
Skillz is trading at $7.13 per share, or 1.1x forward price-to-gross profit. To fully understand why you should be careful with SKLZ, check out our full research report (it’s free for active Edge members).
Clover Health (CLOV)
Share Price: $2.73
Founded in 2014 to improve healthcare for America's seniors through technology, Clover Health (NASDAQ: CLOV) provides Medicare Advantage plans for seniors with a focus on affordable care and uses its proprietary Clover Assistant software to help physicians manage patient care.
Why Are We Cautious About CLOV?
- Sales tumbled by 18.1% annually over the last two years, showing market trends are working against its favor during this cycle
- Revenue base of $1.61 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
- Cash-burning history makes us doubt the long-term viability of its business model
Clover Health’s stock price of $2.73 implies a valuation ratio of 16.8x forward P/E. Read our free research report to see why you should think twice about including CLOV in your portfolio.
Stocks We Like More
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
